Patients with DME achieved better long-term visual
outcomes when treated with ranibizumab (Lucentis,
Genentech) and focal/grid laser combination therapy
than with ranibizumab or laser alone, according to the
results of the phase 2 READ-2 study publishe…
Carl Zeiss Introduces Multispot Photocoagulation Laser
Carl Zeiss Meditec, Inc. (Dublin, CA), introduced the
Visulas 532s Vite photocoagulator at the AAO in Chicago.
The device recently received marketing clearance from
the FDA. According to the company, the Visulas 532s Vite
photocoagulator features varia…
FAME: 24-month Readout Shows Steady Improvement
Vision continued to significantly improve at 2 years with
the fluocinolone acetonide intravitreal insert (Iluvien,
Alimera Sciences), according to Baruch D. Kuppermann,
MD, PhD, who presented the 24-month readout of the
FAME trial at the American Acade…
Accumulated Doses of Irradiation to the Lens May be Cataractogenic
Irradiation toxic effects of intra-arterial chemotherapy
may be cataractogenic and possibly carcinogenic, especially
in irradiation-sensitive patients with retinoblastoma,
according to a study published in the Archives of
Ophthalmology.1
The prospectiv…
EyeGate to Develop Corticosteroid Solution for Retinal Disorders
EyeGate Pharma (Waltham, MA) announced that it
has received four federal grants totaling nearly $1 million
for programs that focus on the continued clinical development
of EGP-437, a corticosteroid solution administered by the EyeGate II delivery syste…
Omega-3s In Fish, Seafood May Protect Seniors’ Eyes; A New Test May Catch Glaucoma Early
SAN FRANCISCO, CA- Seniors interested in lifestyle choices that help protect vision will be encouraged by a Johns Hopkins School of Medicine study, and people concerned about glaucoma can take heart from work on early detection by the University of Mia…